Fenoterol hydrobromide and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenoterol hydrobromide (fenoterol hydrobromide) and Methotrexate (methotrexate sodium). Common drug interactions include asthma among females and bronchopulmonary aspergillosis among males.

The phase IV clinical study analyzes what interactions people have when they take Fenoterol hydrobromide and Methotrexate. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Fenoterol hydrobromide?

Fenoterol hydrobromide has active ingredients of fenoterol hydrobromide. eHealthMe is studying from 1,327 Fenoterol hydrobromide users. Check the latest studies of Fenoterol hydrobromide.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.



On Jul, 11, 2026

21 people who take Fenoterol hydrobromide and Methotrexate together, and have interactions are studied.

Fenoterol hydrobromide and Methotrexate drug interactions.

What are the common drug interactions of Fenoterol Hydrobromide and Methotrexate, by gender? *:

female:

  1. Asthma
  2. Respiratory syncytial virus infection (viral disease of respiratory system)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Renal failure (kidney dysfunction)
  5. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Cystitis viral (inflammation of the wall of the bladder by virus)
  8. Dyspnoea (difficult or laboured respiration)
  9. Human herpesvirus 6 infection
  10. Hysterectomy

male:

  1. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  2. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  3. Haemoglobinaemia (excess of haemoglobin in the blood plasma)
  4. Human herpesvirus 6 infection
  5. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  8. Dyskinesia (abnormality or impairment of voluntary movement)
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Loss of consciousness

What are the common drug interactions of Fenoterol Hydrobromide and Methotrexate, by age (0-1 to 60+)? *:

0-1:

  1. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  2. Haemoglobinaemia (excess of haemoglobin in the blood plasma)
  3. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  4. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

2-9:

  1. Cystitis viral (inflammation of the wall of the bladder by virus)
  2. Human herpesvirus 6 infection
  3. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  4. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Cystitis viral (inflammation of the wall of the bladder by virus)
  4. Human herpesvirus 6 infection
  5. Rash
  6. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

50-59:

  1. Asthma
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Dyskinesia (abnormality or impairment of voluntary movement)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Loss of consciousness

60+:

  1. Benign prostatic hyperplasia (benign enlargement of the prostate)
  2. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  3. Infection
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Vocal cord paralysis
  7. Constipation
  8. Dysuria (painful or difficult urination)
  9. Lipase increased
  10. Respiratory syncytial virus infection (viral disease of respiratory system)

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 33.33%
  2. Abdominal Pain: 6 people, 28.57%
  3. Back Pain: 6 people, 28.57%
  4. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 6 people, 28.57%
  5. Bone Marrow Conditioning Regimen: 6 people, 28.57%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 28.57%
  7. Adverse Event: 6 people, 28.57%
  8. Constipation: 5 people, 23.81%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 14.29%
  10. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Fenoterol hydrobromide and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fenoterol hydrobromide and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fenoterol hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fenoterol hydrobromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fenoterol hydrobromide and methotrexate sodium (the active ingredients of Fenoterol hydrobromide and Methotrexate, respectively), and Fenoterol hydrobromide and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: